Prostate cancer: Hypofractionated radiotherapy’s role in post-operative settings

Hypofractionated external beam radiotherapy delivers the total prescribed therapeutic radiotherapy dose in fewer, larger-dose fractions than standard radiotherapy dose schedules, accelerating treatment time. “The key advantages of moderate hypofractionation, owing to its shorter treatment courses, are lower cost and greater convenience for patients,” said Scott Morgan, MD, assistant professor of radiation oncology at the University of Ottawa in Canada.
Cancer Therapy Advisor